Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Pantaleo: RepliVax Vaccine Platform |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-01-24 |
| Study Made Public: | 2016-10-12 |
Title
Targeting HIV-1 Env Gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques
Description
CAVD 408 (AUP 518) is a non-human primate study comparing NYVAC/protein-adjuvant prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
GLA Poly ICLC Placebo Unspecified NYVAC-KC-gp140(ZM96) gp140 Lox-1Integrated data
BAMA, ICS, NAb
Non-integrated data
No non-integrated data is available for this study.